航天彩虹(002389.SZ):彩虹6/7/10屬大型無人機 研發所需週期較長
格隆匯5月25日丨有投資者在投資者互動平台向航天彩虹(002389.SZ)提問,“公司研發目前主要任務是在哪幾款機型,公司一直説在研發但始終沒有實現最終產品,公司的彩虹6,7,10時間表是什麼大概可以最終量產投入?”
航天彩虹(002389.SZ)回覆稱,公司在研機型詳情請參閲2022年年報“第三節 管理層討論與分析"。彩虹6/7/10屬大型無人機,研發所需週期較長,要經歷從預研、立項、設計、研製、試驗到定型、量產,且需要投入大量資源,其量產時間表將視研製進展和用户採購計劃而定。部分產品的研發進度請參閲公司2023年3月30日“關於調整部分募集資金投資項目計劃進度的公吿”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.